Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pan İmmun İnflamatuar İndeks (PIV) Ile Endometriosiz Arasındaki İlişki

NCT06142214 is registered in ClinicalTrials.gov with Ankara Etlik City Hospital as lead sponsor.

NCT NCT06142214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06142214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pan İmmun İnflamatuar İndeks (PIV) Ile Endometriosiz Arasındaki İlişki
Lead sponsor
Ankara Etlik City Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 9, 2023
Completion date
February 15, 2024
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

relationship between pan immune inflammatory index and endometriosis and endometriosis stages